This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, M. C.
Right arrow Articles by Seppala, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, M. C.
Right arrow Articles by Seppala, H.

Next Article 

Antimicrobial Agents and Chemotherapy, December 1999, p. 2823-2830, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

MINIREVIEW

Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants

Marilyn C. Roberts,1,* Joyce Sutcliffe,2 Patrice Courvalin,3 Lars Bogo Jensen,4 Julian Rood,5 and Helena Seppala6

Department of Pathobiology, University of Washington, Seattle, Washington 981951; Department of Infectious Diseases, Pfizer Central Research, Groton, Connecticut 06340-15962; Unite des Agents Antibacterienes, Institute Pasteur, Paris Cedex 15, France3; Danish Veterinary Laboratory, DK-1790 Copenhagen, Denmark4; Department of Microbiology, Monash University, Clayton, Victoria 3168, Australia5; and Antimicrobial Research Laboratory, National Public Health Institute, FIN-20520 Turku, Finland6


    INTRODUCTION
Top
Introduction
Conclusion
References

Macrolides are composed of 14 (erythromycin and clarithromycin)-, 15 (azithromycin)-, or 16 (josamycin, spiramycin, and tylosin)-membered lactones to which are attached amino and/or neutral sugars via glycosidic bonds. Erythromycin was introduced in 1952 as the first macrolide antibiotic. Unfortunately, within a year, erythromycin-resistant (Emr) staphylococci from the United States, Europe, and Japan were described (101). Erythromycin is produced by Saccharopolyspora erythraea, while the newer macrolides are semisynthetic molecules with substitutions on the lactone. The newer derivatives, such as clarithromycin and azithromycin, have improved intracellular and tissue penetration, are more stable, are better absorbed, have a lower incidence of gastrointestinal side effects, and are less likely to interact with other drugs. They are useable against a wider range of infectious bacteria, such as Legionella, Chlamydia, Haemophilus, and some Mycobacterium species (not M. tuberculosis), and their pharmacokinetics provide for less frequent dosing than erythromycin (21, 47, 96, 97). As a result, the usage of the newer macrolides has increased dramatically over the last few years, which has led to increased exposure of bacterial populations to macrolides (101-103, 107).

Macrolides inhibit protein synthesis by stimulating dissociation of the peptidyl-tRNA molecule from the ribosomes during elongation (101, 103). This results in chain termination and a reversible stoppage of protein synthesis. The first mechanism of macrolide resistance described was due to posttranscriptional modification of the 23S rRNA by the adenine-N6 methyltransferase (101-103). These enzymes add one or two methyl groups to a single adenine (A2058 in Escherichia coli) in the 23S rRNA moiety. Over the last 30 years, a number of adenine-N6-methyltransferases from different species, genera, and isolates have been described. In general, genes encoding these methylases have been designated erm (erythromycin ribosome methylation), although there are exceptions, especially in the antibiotic-producing organisms (see Tables 1 and 3) (103). As the number of erm genes described has grown, the nomenclature for these genes has varied and has been inconsistent (Table 1). In some cases, unrelated genes have been given the same letter designation, while in other cases, highly related genes (>90% identity) have been given different names.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   rRNA methylase genes involved in MLSB resistance

The binding site in the 50S ribosomal subunit for erythromycin overlaps the binding site of the newer macrolides, as well as the structurally unrelated lincosamides and streptogramin B antibiotics. The modification by methylase(s) reduces the binding of all three classes of antibiotics, which results in resistance against macrolides, lincosamides, and streptogramin B antibiotics (MLSB). The rRNA methylases are the best studied among macrolide resistance mechanisms (47, 101-103). However, a variety of other mechanisms have been described which also confer resistance (Table 2). Many of these alternative mechanisms of resistance confer resistance to only one or two of the antibiotic classes of the MLSB complex.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Efflux and inactivating genes

In this review, we suggest a new nomenclature for naming MLS genes and propose to use the rules developed for identifying and naming new tetracycline resistance genes (51, 52). This system, with a few recent modifications, was originally designed because of the ability of two genes to be distinguished uniquely by DNA-DNA probe methodology (51). It was generally found that two genes with <80% amino acid sequence identity provided enough variability in nucleotide sequence to permit distinct probes to be designed. Although many investigators are likely to sequence new genes, the use of probe technology allows rapid identification of isolates containing potentially new genes, as well as a reliable way to screen populations and determine the frequency of any one resistant determinant. Therefore, we continued this paradigm by assigning two genes of >= 80% amino acid identity to the same class and same letter designation, while two genes that show <= 79% amino acid identity are given a different letter designation. Table 1 shows the results of the classification, with some classes having members with little variability, while others, like classes A and O, show a greater range of homology at both the DNA and amino acid levels. As new gene sequences emerge, ideally they will need to be compared by oligonucleotide probe hybridization and/or sequence analysis against the bank of known genes before a new designation is assigned. If multiple genes are available in any one class, especially when there is a range as in class A, then all representative members of the class should be examined, not just one. To confirm that the proposed name or number for the newly discovered resistance determinant has not been used by another investigator, please contact M. C. Roberts for this information. A similar request has been made for new tet genes (52).


    RRNA METHYLASES

Over the last 30 years, a large number of different rRNA methylase genes (erm) have been isolated from a variety of bacteria that range from E. coli to Haemophilus influenzae in gram-negative species and from Streptococcus pneumoniae to Corynebacterium spp. in gram-positive species (Table 3). In addition, a variety of gram-positive and gram-negative anaerobes, and even spirochetes such as Borrelia burgdorferi and Treponema denticola, have all been shown to carry erm genes (Table 3) (36, 77, 78). All erm enzymes methylate the same adenine residue, resulting in an MLSB phenotype (9, 100-103). This adenine (A2058) or one of the adjacent residues in the peptidyltransferase region (A2057 or A2059) is changed to another nucleotide by mutation in macrolide-resistant Mycobacterium intracellulare, Mycobacterium avium, Propionibacterium spp., and Helicobacter pylori (58, 84, 100-103).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 3.   Location of antibiotic resistance genesa

Differences between the various erm genes are seen in the regulation of expression of the phenotype. Some of the enzymes are inducibly regulated by translational attenuation of a mRNA leader sequence; in the absence of erythromycin, the mRNA is in an inactive conformation due to a sequestered Shine-Dalgarno sequence, preventing efficient initiation of translation of the erm transcripts. Mutational analyses of the erm(C) leader peptide suggested that the peptide, (FS)IFVI, is critical for induction (103). However, when the erm peptides from the erm genes are compared, little sequence similarity is apparent (103). Recently, a second mechanism of regulation has been described in which the lack of erythromycin prevents the complete synthesis of the mRNA due to rho factor-independent termination. This type of regulation has been described for the erm(K) system (20), and by homology, we hypothesize that it may also exist for erm(D), as well as erm(J), because they are highly related and have been grouped together under class D (Table 1). In either system, inducible isolates, when tested, may appear to be susceptible or intermediately resistant to macrolides and susceptible to lincosamides. Erythromycin is generally a good inducer in most species; in animal or human streptococcal isolates, lincosamides and/or streptogramin B may be good inducers (47, 76). Good overviews of regulation of the erm genes can be found in recent reviews by Weisblum (100-103).

Inducible strains predominated in the 1960s to 1970s. However, today it is more common in many geographical areas to find isolates that constitutively produce the rRNA methylase without preexposure to antibiotics. Constitutive erm gene expression is usually associated with structural alterations in the erm translational attenuator, including deletions, duplications, and point mutations in erm(C) (104). They can be distinguished from inducible isolates by the stable MICs for them regardless of whether they are pregrown with or without an inducer (76, 102).

Many of the erm genes are associated with conjugative or nonconjugative transposons which tend to reside on the chromosomes, although some have been found in plasmids. They are often associated with other antibiotic resistance genes, especially tetracycline resistance genes. The erm(F) gene is often linked with the tet(Q) gene, while the erm(B) gene is often linked with the tet(M) gene (24, 86, 95). These conjugative transposons can have a wide host range, which may explain why clinical isolates of many different bacterial species have been found to carry these erm genes (Table 3). The erm genes in general have low G+C contents (31 to 34%), while the overall chromosomal G+C contents found in gram-negative species are >= 50% and ~35% in gram-positive species.

It has been common practice for investigators to give their erm gene a new name regardless of the DNA and predicted amino acid sequence similarity to previously characterized erm genes and without regard to whether the gene resides in a different isolate, species, or genus. The result has been that, over the years, the names of these erm genes have become confusing, and often a complex table is required to remember which genes are closely related (Table 1). In the worst cases, genes for unrelated enzymes have been given the same name (erm(A), causing confusion in the literature and GenBank listings (Table 1). The opposite also has occurred where very closely related or virtually identical enzymes have been given a variety of different names. For example, erm(F) (GenBank no. M14730) is found on the Bacteroides transposons Tn4351 and Tn4000 (71), erm(FS) (no. M17808) is on Bacteroides transposon Tn4551 (91), and erm(FU) (no. M62487) (32) is also from Bacteriodes. All three enzymes share >= 97% DNA and amino acid identity (Table 1). Since there are no phenotypic differences between the three erm(F) genes and distinguishing them by any method other than sequencing is problematic, we propose that all three should be known as class F: the Erm(F) protein and the erm(F) gene (Table 1).

The situation is even worse with class B, which is composed of a larger number of genes, including erm(AM), erm(B), erm(BC), erm(BP), and erm(Z), whose sequences share >= 98% homology (Table 1). Because the normal gene designation is to use a single letter (26) and the possibility of confusion between erm(A) and erm(AM), we propose that this group be known as class B: the erm(B) genes and the Erm(B) protein (Table 1). Recent dendrograms of many of the erm genes can be found in articles by Seppälä et al. (88) and Matsuoka et al. (56) and support this grouping of all of these genes within the class B designation.

To help those in the field, GenBank numbers or references for sequences that have not been deposited are listed in Table 1. If a new gene sequence shows >= 80% amino acid homology to any member of a gene class and confers a similar phenotype to the host, we propose that the new gene be placed in the existing group and not be given a new letter or number designation. Thus, with classes that show a wide range of homologies, like class A (81% amino acid homology) or class O (84% amino acid homology), multiple members must be compared to the new gene. Note that the class designation is based on the amino acid sequence of the structural gene only and does not include the various regulatory sequences that can occur upstream of the gene. These guidelines are intended to apply to all of the N-methyltransferases, regardless of whether the gene was originally identified in pathogenic, opportunistic, normal flora bacteria or an antibiotic-producing species. Once all of the single capital letters have been used to identify new erm genes, we recommend naming genes as follows: erm(30), erm(31), etc. This system has been proposed for naming of new tet genes [tet(30), etc.] (52). Furthermore, a similar set of guidelines should be adopted for the genes that encode other mechanisms of resistance to any of the MLS antibiotics (Table 1). Class Y for gene erm(GM), class S for gene erm(SF), class T for gene erm(GT), class V for gene erm(SV), class X for genes erm(CD), erm(CX), and erm(A), and class 2 for gene srm(D) are new class designations that conform to the single-letter designation (Table 1).

There are a number of other methylase genes, most often found in methylase-producing organisms which have not been given erm designations, such as tlr(D), car(B), myr(B), and smr(A). All are from species which confer resistance to a 16-membered ring macrolide (Table 1). We have grouped and renamed them classes H for car(B), I for mdm(A), N for tlr(D), O for genes lrm and srm(A), U for lmr(B), and W for myr(B). The clr gene could not be classified, because there is no sequence in the database or literature available. Less work has been done to determine if these genes are found outside their respective antibiotic producers (Table 3). erm genes are often linked with tet genes, and since genes conferring resistance to oxytetracycline, originally found in antibiotic-producing streptomycetes, are now found in some clinical Mycobacterium isolates, it is certainly possible that some erm genes have also moved into Mycobacterium spp. and other genera (68).

To prevent two unrelated genes from being given the same designation, we propose to establish a reference center, as has recently been recommended for tetracycline resistance genes. By using the guideline presented above in governing the identification of new erm genes, surveys can be conducted in bacterial populations to examine the spread of particular MLSB-resistant determinants. A single internal DNA fragment or oligonucleotide probe or a PCR assay that detects all members of a gene class can be established to screen large numbers of isolates. Not only will the adoption of a uniform naming system reduce the number of new erm gene names, but it will hopefully prevent confusion over unrelated genes being given the same designation and also prevent highly related genes from having different gene designations.


    EFFLUX SYSTEMS

A number of different antibiotic resistance genes code for transport (efflux) proteins. These do not modify either the antibiotic or the antibiotic target, but instead pump the antibiotic out of the cell or the cellular membrane, keeping intracellular concentrations low and ribosomes free from antibiotic. Many of these proteins [mef(A), mef(E), and lmr(A)] have homology to the major facilitator superfamily (MFS) of efflux proteins. Others [car(A), msr(A), msr(B), ole(B), ole(C) srm(B), tlr(C), vga, and vga(B)] are putative members of the ABC transporter superfamily (70). In early years, most macrolide resistance was mediated by the presence of erm genes. However, more recently, other mechanisms of macrolide resistance have been found in increasing frequency in certain gram-positive populations (23, 27, 41, 43, 44, 92, 93, 106). Three different efflux systems which confer resistance have been described for gram-positive cocci [msr(A) (macrolide and streptogramin B resistant), mef(A) (macrolide efflux), and vga and vga(B) (virginiamycin factor A)] (4) (Table 2). Besides the academic interest in these genes, their presence in an erythromycin-resistant bacterial pathogen of interest may also have implications in terms of therapeutic choices. If an isolate carries a mef gene, clindamycin can be considered, whereas the presence of an erm(B) gene would preclude consideration of a lincosamide. Recently, we and others have identified Streptococcus pneumoniae strains which carry both mef and erm(B) genes and, as expected, have the MLSB phenotype (41, 53).

The mef genes have been found in a variety of gram-positive genera, including corynebacteria, enterococci, micrococci, and a variety of streptococcal species (30, 43, 53, 90) (Table 3), suggesting a much wider distribution of this group of genes than originally imagined. Many of these genes are associated with conjugative elements located in the chromosome and are readily transferred conjugally across species and genus barriers (43, 53).

Two mef genes have been characterized in the literature: mef(A) (23) and mef(E) (94). The mef(A) gene was described in Streptococcus pyogenes, while the mef(E) gene was found in S. pneumoniae. Since the two genes share 90% DNA and 91% amino acid homology (Table 2), we recommended that these two genes be considered a single class, A: mef(A) gene and Mef(A) protein (Table 2).

The msr(A), msr(SA), msr(SA)', and msr(B) group differs from the mef genes because they confer resistance to both macrolide and streptogramin B antibiotics (MS) (13, 55-57). The msr(B) gene is roughly half the size of msr(A), but very homologous to it. Though this gene is significantly shorter than the msr(A) gene sequence, we placed it with the other msr genes (Table 2).

In antibiotic producers, there are efflux pumps specific for MLSB antibiotics that generally belong to the ABC transporter superfamily (87). They include car(A) from Streptomyces thermotolerans (87), ole(B) from Streptomyces antibioticus (7, 80), srm(B) from Streptomyces ambofaciens (73), lmr(C) from Streptomyces lincolnensis (70), and tlr(C) from Streptomyces fradiae (87). In addition to the msr(A) efflux pumps, there are two efflux systems identified in staphylococci that confer resistance to streptogramin A antibiotics, vga and vga(B) (4). Besides mef(A), other efflux proteins that appear to be fueled by the proton motive force have been described for MLSB antibiotics. A lincomycin-specific efflux pump encoded by lmr(A) has been described in S. lincolnensis (110).


    OTHER MECHANISMS

A variety of other mechanisms which usually confer resistance to only one of the three classes (M, L, or S) or one component such as streptogramin A, but not streptogramin B, have been described (103) (Table 2). These proteins modify the antibiotic rather than the rRNA target or serve as pumps that shuttle the antibiotic out of the bacterial cell. Enzymes which hydrolyze streptogramin B [vgb (virginiamycin factor B hydrolase), vgb(B) genes] or modify the antibiotic by adding an acetyl group (acetyltransferases) to streptogramin A [vat (virginiamycin, factor A acetylation), vat(B), vat(C), sat(A), and sat(G) genes] have been described (1-6) (Table 2). Many of these genes are plasmid borne, and often these vat-related genes [vat, vat(B), and vat(C) genes] are downstream of other genes encoding resistance to streptogramins [vgb, vga(B), and vgb(B) genes, respectively] in staphylococci (2), but not in enterococci (72). The acetyltransferase genes are related, in the active site region, to a novel chloramphenicol acetyltransferase family of enzymes. We have renamed sat(A) as vat(D) and sat(G) as vat(E) to simplify the nomenclature (Table 2).

Unlike most of the other genes described in this review, both the ere (erythromycin esterification) and mph (macrolide phosphotransferase) genes (Table 2) were first described in E. coli rather than gram-positive cocci (8, 63, 64, 66, 67). According to our guidelines, mph(K) has been reassigned to mph(A), because there are only 10 amino acid (1%) differences between the two proteins. mph(BM) and mph(C) (66a) are grouped under Mph(C), because these genes are nearly identical to each other and distinct from mph(A) and mph(B) (Table 2). Several lincomycin nucleotidyltransferases have been identified: lin(A) in Staphylococcus haemolyticus (16), lin(A)' in Staphylococcus aureus (17), and lin(B) in Enterococcus faecium (14). We propose changing lin(A) and lin(B) to lnu(A) and lnu(B) (for lincomycin nucleotidyltransferase), because the former letters have already been used for gamma BHC dehydrochlorinase and cyclohexadiene hydrolase genes. It is suggested that prior to naming a new gene class, it is necessary to determine if the proposed three-letter designation has been used for other previously characterized genes.


    CONCLUSIONS
Top
Introduction
Conclusion
References

With the introduction of the newer, more stable macrolides with enhanced properties, there has been a significant increase in macrolide usage. Macrolides like azithromycin and clarithromycin are recommended for prophylactic use to prevent Mycobacterium avium complex disease in human immunodeficiency virus patients. As macrolide use increases, so does its exposure to bacterial populations, increasing the opportunity for bacteria to acquire macrolide or MLS resistance. Given that intragenic transfer of macrolide-resistant determinants is possible (15), it is likely that all of the genes described in this review will spread into new species and that new genes will be identified. Therefore, it is important to clarify the nomenclature of these resistance genes for their expanding audience.


    ACKNOWLEDGMENTS

We thank M. Matsuoka for providing unpublished material; B. Weisblum for discussions; J. Davies, C. J. Smith, and S. Schwarz for reading the manuscript; and S. Lerner for doing sequence comparisons.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195. Phone: (206) 543-8001. Fax: (206) 543-3873. E-mail: marilynr{at}u.washington.edu.


    REFERENCES
Top
Introduction
Conclusion
References

1. Allignet, J., and N. El Solh. 1995. Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB. Antimicrob. Agents Chemother. 39:2027-2036[Abstract].
2. Allignet, J., N. Liassine, and N. El Solh. 1998. Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics. Antimicrob. Agents Chemother. 42:1794-1798[Abstract/Free Full Text].
3. Allignet, J., V. Loncle, C. Simenel, M. Delepierre, and N. El Solh. 1993. Sequence of a staphylococcal gene, vat, encoding an acetyltransferase inactivating the A-type compounds of virginiamycin-like antibiotics. Gene 130:91-98[Medline].
4. Allignet, J., V. Loncle, and N. El Solh. 1992. Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginianmycin A-like antibiotics. Gene 117:45-51[Medline].
5. Allignet, J., V. Loncle, P. Mazodier, and N. El Solh. 1988. Nucleotide sequence of a staphylococcal plasmid gene, vgb, encoding a hydrolase inactivating the B components of virginiamycin-like antibiotics. Plasmid 20:271-275[Medline].
6. Allignet, J., and N. El Solh. 1995. Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB. Antimicrob. Agents Chemother. 39:2027-2036.
7. Aparicio, G., A. Buche, C. Mendez, and J.-A. Salas. 1996. Characterization of the ATPase activity of the N-terminal nucleotide binding domain of an ABC transporter involved in oleandomycin secretion by Streptomyces antibioticus. FEMS Microbiol. Lett. 141:157-162[Medline].
8. Arthur, M., A. Andremont, and P. Courvalin. 1987. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob. Agents Chemother. 31:404-409[Abstract/Free Full Text].
9. Arthur, M., A. Brisson-Noel, and P. Courvalin. 1987. Origin and evolution of genes specifying resistance to macrolides, lincosamides and streptogramin antibiotics: data and hypothesis. J. Antimicrob. Chemother. 20:783-802[Free Full Text].
10. Berryman, D. I., and J. I. Rood. 1989. Cloning and hybridization analysis of ermP, a macrolide-lincosamide-streptogramin B resistance determinant from Clostridium perfringens. Antimicrob. Agents Chemother. 33:1346-1353[Abstract/Free Full Text].
11. Berryman, D. I., and J. I. Rood. 1995. The closely related ermB-ermAM genes from Clostridium perfringens, Enterococcus faecalis (pAMbeta 1), and Streptococcus agalactiae (pIP501) are flanked by variants of a directly repeated sequence. Antimicrob. Agents Chemother. 39:1830-1834[Abstract].
12. Berryman, D. I., M. Lyristis, and J. I. Rood. 1994. Cloning and sequence analysis of ermQ, the predominant macrolide-lincosamide-streptogramin B resistance gene in Clostridium perfringens. Antimicrob. Agents Chemother. 38:1041-1046[Abstract/Free Full Text].
13. Beyer, D., and K. Pepper. 1998. The streptogramin antibiotics: update on their mechanism of action. Exp. Opin. Investig. Drugs 7:591-599.
14. Bozdogan, B., L. Berrezouga, M.-S. Kuo, D. A. Yurek, K. A. Farley, B. J. Stockman, and R. LeClercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob. Agents Chemother. 43:925-929[Abstract/Free Full Text].
15. Brisson-Noël, A., M. Arthur, and P. Courvalin. 1988. Evidence for natural gene transfer from gram-positive cocci to Escherichia coli. J. Bacteriol. 170:1739-1745[Abstract/Free Full Text].
16. Brisson-Noel, A., and P. Courvalin. 1986. Nucleotide sequence of gene linA encoding resistance to lincosamides in Staphylococcus haemolyticus. Gene 43:247-253[Medline].
17. Brisson-Noel, A., P. Delrieu, D. Samain, and P. Courvalin. 1988. Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes. J. Biol. Chem. 263:15880-15887[Abstract/Free Full Text].
18. Calcutt, M. J., and E. Cundliffe. 1990. Cloning of a lincosamide resistance determinant from Streptomyces caelestis, the producer of celesticetin, and characterization of the resistance mechanism. J. Bacteriol. 172:4710-4714[Abstract/Free Full Text].
19. Cheng, J., T. Grebe, L. Wondrack, P. Courvalin, and J. Sutcliffe. 1999. Characterization of genes involved in erythromycin resistance in a clinical strain of Staphylococcus aureus, abstr. 837, p. 114. In Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Choi, S.-S., S.-K. Kim, T.-G. Oh, and E.-C. Choi. 1997. Role of mRNA termination in regulation of ermK. J. Bacteriol. 179:2065-2067[Abstract/Free Full Text].
21. Chu, D. 1995. Recent developments in 14- and 15-membered macrolides. Exp. Opin. Investig. Drugs 4:65-94.
22. Chung, W. O., C. Werckenthin, S. Schwarz, and M. C. Roberts. 1999. Host range of the ermF rRNA methylase gene in human and animal bacteria. J. Antimicrob. Chemother. 43:5-14[Abstract/Free Full Text].
23. Clancy, J., J. W. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. Kamath, J. Bergeron, and J. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant mefA from Streptococcus pyogenes. Mol. Microbiol. 22:867-879[Medline].
24. Clewell, D. B., S. E. Flannagan, and D. D. Jaworski. 1995. Unconstrained bacterial promiscuity: the Tn916-Tn1545 family of conjugative transposons. Trends Microbiol. 3:229-236[Medline].
25. Cooper, A. J., N. B. Shoemaker, and A. A. Salyers. 1996. The erythromycin resistance gene from the Bacteroides conjugal transposon Tcr Emr 7853 is nearly identical to ermG from Bacillus sphaericus. Antimicrob. Agents Chemother. 40:506-508[Abstract].
26. Council of Biology Editors, Inc. 1983. CBE style manual: a guide for authors, editors, and publishers in the biological sciences, 5th ed. Council of Biology, Editors, Inc., Bethesda, Md
27. Eady, E. A., J. I. Ross, J. L. Tipper, C. E. Walters, J. H. Cove, and W. C. Noble. 1993. Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J. Antimicrob. Chemother. 31:211-217[Abstract/Free Full Text].
28. Epp, J. K., S. G. Burgett, and G. E. Schoner. 1987. Cloning and nucleotide sequence of a carbomycin-resistance gene from Streptomyces thermotolerans. Gene 53:73-83[Medline].
29. Farrow, K. A., D. Lyras, and J. I. Rood. GenBank accession no. AF109075.
30. Fraimow, H., and C. Knob. 1997. Amplification of macrolide efflux pumps msr and mef from Enterococcus faecium by polymerase chain reaction, abstr. A-125, p. 22. In Abstracts of the 98th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
31. Hächler, H., F. H. Kayser, and B. Berger-Bächi. 1987. Homology of a transferable tetracycline resistance determinant of Clostridium difficile with Streptococcus (Enterococcus) faecalis transposon Tn916. Antimicrob. Agents Chemother. 31:1033-1038[Abstract/Free Full Text].
32. Halula, M., S. Manning, and F. L. Macrina. 1991. Nucleotide sequence of ermFU, macrolide-lincosamide-streptogramin (MLS) resistance gene encoding an RNA methylase from the conjugal element of Bacteroides fragilis V503. Nucleic Acids Res. 19:3453[Free Full Text].
33. Hammerum, A. M., L. Jensen, L. Bogo, and F. M. Aarestrup. 1998. Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals. FEMS Microbiol. Lett. 168:145-151[Medline].
34. Hara, Q., and C. R. Hutchinson. 1990. Cloning of midecamycin (MLS)-resistance genes from Streptomyces mycarofaciens, Streptomyces lividans and Streptomyces coelicolor A3(2). J. Antibiot. (Tokyo) 43:977-991[Medline].
35. Hodgson, A. L. M., J. Krywult, and A. J. Radford. 1990. Nucleotide sequence of the erythromycin resistance gene from Corynebacterium plasmid pNG2. Nucleic Acids Res. 18:1891[Free Full Text].
36. Hudson, C. R., M. C. Roberts, and F. C. Gherardini. 1998. Evidence of conjugal transfer of an erythromycin-resistance determinant in Borrelia burgdorferi, abstr. D-2, p. 223. In Abstracts of the 98th Annual Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
37. Inouye, M., T. Morohoshi, S. Horinouchi, and T. Beppu. 1994. Cloning and sequences of two macrolides-resistance-encoding genes from mycinamicin-producing Micromonospora griseorubida. Gene 141:39-46[Medline].
38. Jenkins, G., M. Zalacain, and E. Cundliffe. 1989. Inducible ribosomal RNA methylation in Streptomyces lividans, conferring resistance to lincomycin. J. Gen. Microbiol. 129:2703-2714.
39. Jensen, L. B., A. M. Hammerum, F. M. Aarestrup, A. E. van den Bogaard, and E. E. Stobberingh. 1998. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in The Netherlands. Antimicrob. Agents Chemother. 42:3330-3331[Free Full Text].
40. Jensen, L. B., N. Frimodt-Moller, and F. M. Aarestrup. 1999. Presence of erm gene classes in Gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiol. Lett. 170:151-158[Medline].
41. Johnston, N. J., J. C. de Azavedo, J. D. Kellner, and D. E. Low. 1998. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2425-2426[Abstract/Free Full Text].
42. Kamimiya, S., and B. Weisblum. 1996. GenBank deposit: Streptomyces viridochromogenes rRNA (adenine-N6-) methyltransferase, ermSV gene. Accession no. U59450
43. Kataja, J., H. Seppälä, M. Skurnik, H. Sarkkinen, and P. Huovinen. 1998. Different erythromycin resistance mechanisms in group C and group G streptococci. Antimicrob. Agents Chemother. 42:1493-1494[Abstract/Free Full Text].
44. Kataja, J., P. Huovinen, M. Skurnik, the Finnish Study Group for Antimicrobial Resistance, and H. Seppälä. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52[Abstract/Free Full Text].
45. Kim, S.-K., M.-C. Baek, S.-S. Choi, B.-K. Kim, and E.-C. Choi. 1996. Nucleotide sequence, expression and transcriptional analysis of the Escherichia coli mphK gene encoding macrolide-phosphotransferase K. Mol. Cells 6:153-160.
46. Kovalic, D., R. B. Giannattasio, H.-J. Jin, and B. Weisblum. 1994. 23S rRNA domain V, a fragment that can be specifically methylated in vitro by the ErmSF (TlrA) methyltransferase. J. Bacteriol. 176:6992-6998[Abstract/Free Full Text].
47. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272[Free Full Text].
48. Leclercq, R., and P. Courvalin. 1991. Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob. Agents Chemother. 35:1273-1276[Free Full Text].
49. Le Goffic, F., M. L. Capmau, M. L. Bonnet, C. Cerceau, C. J. Soussy, A. Dublanchet, and J. Duval. 1977. Plasmid-mediated pristinamycin resistance: PH1A, a pristinamycin 1A hydrolase. Ann. Inst. Pasteur 128:471-474.
50. Le Goffic, F., M. L. Capmau, M. L. Bonnet, C. Cerceau, C. J. Soussy, A. Dublanchet, and J. Duval. 1977. Plasmid-mediated pristinamycin resistance: PCIIA, a new enzyme which modifies pristinamycin IIA. J. Antibiot. 30:665-669[Medline].
51. Levy, S. B., L. M. McMurry, V. Burdett, P. Courvalin, W. Hillen, M. C. Roberts, and D. E. Taylor. 1989. Nomenclature for tetracycline resistance determinants. Antimicrob. Agents Chemother. 33:1373-1374[Abstract/Free Full Text].
52. Levy, S. B., L. M. McMurry, T. M. Barbosa, V. Burdett, P. Courvalin, W. Hillen, M. C. Roberts, J. I. Rood, and D. E. Taylor. 1999. Nomenclature for new tetracycline resistance determinants. Antimicrob. Agents Chemother. 43:1523-1524[Abstract/Free Full Text].
53. Luna, V. A., P. Coates, E. A. Eady, J. Cove, T. T. H. Nguyen, and M. C. Roberts. 1999. A variety of Gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44:19-25[Abstract/Free Full Text].
54. Matsuoka, M., M. Inoue, and Y. Nakajima. 1995. A mechanism of resistance to partial macrolide and streptogramin B antibiotics in Staphylococcus aureus clinically isolated in Hungary. Biol. Pharm. Bull. 18:1482-1486[Medline].
55. Matsuoka, M., M. Inoue, and Y. Nakajima. 1997. A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 148:91-96[Medline].
56. Matsuoka, M., M. Inoue, and Y. Nakajima. 1998. A new class of erm genes mediating MLS-coresistance in Staphylococcus aureus: it resides on plasmid pMS97 together with msrSA' gene coding for an active efflux pump, abstr. C-35, p. 78. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
57. Matsuoka, M., K. Endou, H. Kobayashi, M. Inoue, and Y. Nakajima. 1998. A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol. Lett. 167:221-227[Medline].
58. Meier, A., P. Kirschner, B. Springer, V. A. Steingrube, B. A. Brown, R. J. Wallace, Jr., and E. C. Böttger. 1994. Identification of mutations in the 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare. Antimicrob. Agents Chemother. 38:381-384[Abstract/Free Full Text].
59. Miller, E. S., C. R. Woese, and S. Brenner. 1991. Description of the erythromycin-producing bacterium Arthrobacter sp. strain NRRL B-3381 as Aeromicrobium erythreum gen. nov., sp. nov. Int. J. Syst. Bacteriol. 41:363-368[Abstract/Free Full Text].
60. Milton, I. D., C. L. Hewitt, and C. R. Harwood. 1992. Cloning and sequencing of a plasmid-mediated erythromycin resistance determinant from Staphylococcus xylosus. FEMS Microbiol. Lett. 76:141-147[Medline].
61. Monod, M., C. Denoya, and D. Dubnau. 1986. Sequence and properties of pIM13, a macrolide-lincosamide-streptogramin B resistance plasmid from Bacillus subtilis. J. Bacteriol. 167:138-147[Abstract/Free Full Text].
62. Monod, M., S. Mohan, and D. Dubnau. 1987. Cloning and analysis of ermG, a new macrolide-lincosamide-streptogramin B resistance element from Bacillus sphaericus. J. Bacteriol. 169:340-350[Abstract/Free Full Text].
63. Noguchi, N., A. Emura, H. Matsuyama, K. O'Hara, M. Sasatsu, and M. Kono. 1995. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2'-phosphotransferase I in Escherichia coli. Antimicrob. Agents Chemother. 39:2359-2363[Abstract].
64. Noguchi, N., J. Katayama, and K. O'Hara. 1996. Cloning and nucleotide sequence of the mphB gene for macrolide 2'-phosphotransferase II in Escherichia coli. FEMS Microbiol. Lett. 144:197-202[Medline].
65. Oh, T.-G., A.-R. Kwon, and E.-C. Choi. 1998. Induction of ermAMR from a clinical strain of Enterococcus faecalis by 16-membered-ring macrolide antibiotics. J. Bacteriol. 180:5788-5791[Abstract/Free Full Text].
66. O'Hara, K., T. Kanda, K. Ohmiya, T. Ebisu, and M. Kono. 1989. Purification and characterization of macrolide 2'-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob. Agents Chemother. 33:1354-1357[Abstract/Free Full Text].
66a. O'Hara, K. Personal communication.
67. Ounissi, H., and P. Courvalin. 1985. Nucleotide sequence of the gene ereA encoding the erythromycin esterase in Escherichia coli. Gene 35:271-278[Medline].
68. Pang, Y., B. A. Brown, V. A. Steingrube, R. J. Wallace, Jr., and M. C. Roberts. 1994. Tetracycline resistance determinants in Mycobacterium and Streptomyces species. Antimicrob. Agents Chemother. 38:1408-1412[Abstract/Free Full Text].
69. Pernodet, J. L., M. H. Blondelet-Rouault, and M. Guerineau. 1993. Resistance to spiramycin in Streptomyces ambofaciens, the producer organism, involves at least two different mechanisms. J. Gen. Microbiol. 139:1003-1011[Abstract/Free Full Text].
70. Peschke, U., H. Schmidt, H.-Z. Zhang, and W. Piepersberg. 1995. Molecular characterization of the lincomycin-production gene cluster of Streptomyces lincolnensis 78-11. Mol. Microbiol. 16:1137-1156[Medline].
71. Rasmussen, J. L., D. A. Odelson, and F. L. Macrina. 1986. Complete nucleotide sequence and transcription of ermF, a macrolide-lincosamide-streptogramin B resistance determinant from Bacteroides fragilis. J. Bacteriol. 168:523-533[Abstract/Free Full Text].
72. Rende-Fournier, R., R. LeClercq, M. Galimand, J. Duval, and P. Courvalin. 1993. Identification of the satA gene encoding a streptogramin A acetyltransferase in Enterococcus faecium BM4145. Antimicrob. Agents Chemother. 37:2119-2125[Abstract/Free Full Text].
73. Richardson, M. A., S. Kuhstoss, P. Solenberg, N. A. Schaus, and R. N. Rao. 1987. A new shuttle cosmid vector, pKC505, for streptomycetes: its use in the cloning of three different spiramycin-resistance genes from a Streptomyces ambovaciens library. Gene 61:231-241[Medline].
74. Roberts, A. N., G. S. Hudson, and S. Brenner. 1985. An erythromycin-resistance gene from an erythromycin-producing strain of Arthrobacter sp. Gene 35:259-270[Medline].
75. Roberts, M. C. 1995. Distribution of tetracycline and macrolides-lincosamides-streptogramin B (MLS) genes in anaerobic bacteria. Clin. Infect. Dis. 20:S367-S369.
76. Roberts, M. C., and M. B. Brown. 1994. Macrolide-lincosamide resistance determinants in streptococcal species isolated from the bovine mammary gland. Vet. Microbiol. 40:253-261[Medline].
77. Roberts, M. C., W. O. Chung, and D. E. Roe. 1996. Characterization of tetracycline and erythromycin determinants in Treponema denticola. Antimicrob. Agents Chemother. 40:1690-1694[Abstract].
78. Roberts, M. C., W. O. Chung, D. Roe, M. Xia, C. Marquez, G. Borthagaray, W. L. Whittington, and K. K. Holmes. 1999. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob. Agents Chemother. 43:1367-1372[Abstract/Free Full Text].
79. Roberts, M. C., L. V. McFarland, P. Mullany, and M. E. Mulligan. 1994. Characterization of the genetic basis of antibiotic resistance in Clostridium difficile. J. Antimicrob. Chemother. 33:419-429[Abstract/Free Full Text].
80. Rodriguez, A. M., C. Olano, C. Vilches, C. Mendez, and J. A. Salas. 1993. Streptomyces antibioticus contains at least three olendomycin resistance determinants, one of which shows homology with proteins of the ABC-transporter superfamily. Mol. Microbiol. 8:571-582[Medline].
81. Roe, D. E., A. Weinberg, and M. C. Roberts. 1995. Mobility of rRNA methylase genes in Campylobacter (Wolinella) rectus. J. Antimicrob. Chemother. 36:738-740[Free Full Text].
82. Roe, D. E., A. Weinberg, and M. C. Roberts. 1996. Mobile rRNA methylase genes in Actinobacillus actinomycetemcomitans. J. Antimicrob. Chemother. 37:457-464[Abstract/Free Full Text].
83. Ross, J. I., E. A. Eady, J. H. Cove, and S. Baumberg. 1996. Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene 183:143-148[Medline].
84. Ross, J. I., E. A. Eady, J. H. Cove, C. E. Jones, A. H. Ratyal, Y. W. Miller, S. Vyakrnam, and W. J. Cunliffe. 1989. Clinical resistance to erythromycin and clinidamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob. Agents Chemother. 41:1162-1165[Abstract].
85. Rosteck, P. R., Jr., P. A. Reynolds, and C. L. Hershberger. 1991. Homology between proteins controlling Streptomyces fradiae tylosin resistance and ATP-binding transport. Gene 102:27-32[Medline].
86. Salyers, A. A., N. B. Shoemaker, A. M. Stevens, and L.-Y. Li. 1995. Conjugative transposons: an unusual and diverse set of integrated gene transfer elements. Microbiol. Rev. 59:579-590[Abstract/Free Full Text].
87. Schoner, B., M. Geistlich, P. I. Rosteck, Jr., R. N. Rao, E. Seno, P. Reynolds, K. Cox, S. Burgett, and C. Hershberger. 1992. Sequence similarity between macrolide-resistance determinants and ATP-binding transport proteins. Gene 115:93-96[Medline].
88. Seppälä, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262[Abstract/Free Full Text].
89. Shoemaker, N. B., R. D. Barber, and A. A. Salyers. 1989. Cloning and characterization of a Bacteroides conjugal tetracycline-erythromycin resistance element by using a shuttle cosmid vector. J. Bacteriol. 171:1294-1302[Abstract/Free Full Text].
90. Shortridge, V. D., R. K. Flamm, N. Ramer, J. Beyer, and S. K. Tanaka. 1996. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 26:73-78[Medline].
91. Smith, C. J. 1987. Nucleotide sequence analysis of Tn4551: use of ermFS operon fusions to detect promoter activity in Bacteroides fragilis. J. Bacteriol. 169:4589-4596[Abstract/Free Full Text].
92. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566[Abstract].
93. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824[Abstract].
94. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutcliffe. 1997. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255[Abstract].
95. Trieu-Cuot, P., C. Poyart-Salmeron, C. Carlier, and P. Courvalin. 1990. Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Res. 18:3660[Free Full Text].
96. Vergis, E. N., and V. L. Yu. 1997. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. Semin. Respir. Infect. 12:322-328[Medline].
97. Vergis, E. N., and V. L. Yu. 1998. New macrolides or new quinolones as monotherapy for patients with community-acquired pneumonia; our cup runneth over? Chest 113:1158-1159[Free Full Text].
98. Wasteson, Y., D. E. Robe, K. Falk, and M. C. Roberts. 1996. Characterization of tetracycline and erythromycin resistance in Actinobacillus pleuropneumoniae. Vet. Microbiol. 48:41-50[Medline].
99. Weber, J. M., J. O. Leung, G. T. Main, R. H. B. Potenz, T. J. Paulus, and J. P. DeWitt. 1990. Organization of a cluster of erythromycin genes in Saccharopolyspora erythraea. J. Bacteriol. 172:2372-2383[Abstract/Free Full Text].
100. Weisblum, B. 1999. Resistance to macrolide-lincosamide-streptogramin antibiotics, p. 682-698. In V. A. Fischetti (ed.), Gram-positive pathogens. American Society for Microbiology, Washington, D.C.
101. Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39:577-585[Medline].
102. Weisblum, B. 1995. Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrob. Agents Chemother. 39:797-805[Medline].
103. Weisblum, B. 1998. Macrolide resistance. Drug Resist. Update 1:29-41.
104. Werckenthin, C., S. Schwarz, and H. Westh. 1999. Structural alterations in the translational attenuator of constitutively expressed ermC genes. Antimicrob. Agents Chemother. 43:1681-1685[Abstract/Free Full Text].
105. Werner, G., and W. Witte. 1999. Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to streptogramin A compounds. Antimicrob. Agents Chemother. 43:1813-1814[Free Full Text].
106. Widdowson, C. A., and K. P. Klugman. 1998. Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg. Infect. Dis. 4:277-281[Medline].
107. Young, H., A. Moyes, and A. McMillan. 1997. Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin. Int. J. Sex. Transm. Dis. AIDS 8:299-302.
108. Zalacain, M., and E. Cundliffe. 1989. Methylation of 23S rRNA caused by tlrA (ermSF), a tylosin resistance determinant from Streptomyces fradiae. J. Bacteriol. 171:4254-4260[Abstract/Free Full Text].
109. Zalacain, M., and E. Cundliffe. 1991. Cloning of tlrD, a fourth resistance gene, from the tylosin producer, Streptomyces fradiae. Gene 97:137-142[Medline].
110. Zhang, H.-Z., H. Schmidt, and W. Piepersberg. 1992. Molecular cloning and characterization of two lincomycin-resistance genes, lmrA and lmrB, from Streptomyces lincolnensis 78-11. Mol. Microbiol. 6:2147-2157[Medline].

Antimicrobial Agents and Chemotherapy, December 1999, p. 2823-2830, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Blackman Northwood, J., Del Grosso, M., Cossins, L. R., Coley, M. D., Creti, R., Pantosti, A., Farrell, D. J. (2009). Characterization of Macrolide Efflux Pump mef Subclasses Detected in Clinical Isolates of Streptococcus pyogenes Isolated between 1999 and 2005. Antimicrob. Agents Chemother. 53: 1921-1925 [Abstract] [Full Text]  
  • Nash, K. A., Brown-Elliott, B. A., Wallace, R. J. Jr. (2009). A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae. Antimicrob. Agents Chemother. 53: 1367-1376 [Abstract] [Full Text]  
  • Liu, J., Keelan, P., Bennett, P. M., Enne, V. I. (2009). Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli. J Antimicrob Chemother 63: 423-426 [Abstract] [Full Text]  
  • Varaldo, P. E., Montanari, M. P., Giovanetti, E. (2009). Genetic Elements Responsible for Erythromycin Resistance in Streptococci. Antimicrob. Agents Chemother. 53: 343-353 [Full Text]  
  • Domelier, A.-S., van der Mee-Marquet, N., Arnault, L., Mereghetti, L., Lanotte, P., Rosenau, A., Lartigue, M.-F., Quentin, R. (2008). Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. J Antimicrob Chemother 62: 1227-1233 [Abstract] [Full Text]  
  • Wajima, T., Murayama, S. Y., Sunaoshi, K., Nakayama, E., Sunakawa, K., Ubukata, K. (2008). Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease. J Med Microbiol 57: 1383-1388 [Abstract] [Full Text]  
  • Schwaiger, K., Bauer, J. (2008). Detection of the Erythromycin rRNA Methylase Gene erm(A) in Enterococcus faecalis. Antimicrob. Agents Chemother. 52: 2994-2995 [Full Text]  
  • Achard, A., Guerin-Faublee, V., Pichereau, V., Villers, C., Leclercq, R. (2008). Emergence of Macrolide Resistance Gene mph(B) in Streptococcus uberis and Cooperative Effects with rdmC-Like Gene. Antimicrob. Agents Chemother. 52: 2767-2770 [Abstract] [Full Text]  
  • Fukushima, K. Y., Yanagihara, K., Hirakata, Y., Sugahara, K., Morinaga, Y., Kohno, S., Kamihira, S. (2008). Rapid Identification of Penicillin and Macrolide Resistance Genes and Simultaneous Quantification of Streptococcus pneumoniae in Purulent Sputum Samples by Use of a Novel Real-Time Multiplex PCR Assay. J. Clin. Microbiol. 46: 2384-2388 [Abstract] [Full Text]  
  • Doi, Y., Wachino, J.-i., Arakawa, Y. (2008). Nomenclature of Plasmid-Mediated 16S rRNA Methylases Responsible for Panaminoglycoside Resistance. Antimicrob. Agents Chemother. 52: 2287-2288 [Full Text]  
  • Reinert, R. R., Filimonova, O. Y., Al-Lahham, A., Grudinina, S. A., Ilina, E. N., Weigel, L. M., Sidorenko, S. V. (2008). Mechanisms of Macrolide Resistance among Streptococcus pneumoniae Isolates from Russia. Antimicrob. Agents Chemother. 52: 2260-2262 [Abstract] [Full Text]  
  • Smith, L. K., Mankin, A. S. (2008). Transcriptional and Translational Control of the mlr Operon, Which Confers Resistance to Seven Classes of Protein Synthesis Inhibitors. Antimicrob. Agents Chemother. 52: 1703-1712 [Abstract] [Full Text]  
  • Jacob, M. E., Fox, J. T., Narayanan, S. K., Drouillard, J. S., Renter, D. G., Nagaraja, T. G. (2008). Effects of feeding wet corn distillers grains with solubles with or without monensin and tylosin on the prevalence and antimicrobial susceptibilities of fecal foodborne pathogenic and commensal bacteria in feedlot cattle. J ANIM SCI 86: 1182-1190 [Abstract] [Full Text]  
  • DiPersio, L. P., DiPersio, J. R., Frey, K. C., Beach, J. A. (2008). Prevalence of the erm(T) Gene in Clinical Isolates of Erythromycin-Resistant Group D Streptococcus and Enterococcus. Antimicrob. Agents Chemother. 52: 1567-1569 [Abstract] [Full Text]  
  • Camilli, R., Del Grosso, M., Iannelli, F., Pantosti, A. (2008). New Genetic Element Carrying the Erythromycin Resistance Determinant erm(TR) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 52: 619-625 [Abstract] [Full Text]  
  • Ponticelli, C. (2008). New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients. Nephrol Dial Transplant 23: 27-32 [Full Text]  
  • Chen, J., Yu, Z., Michel, F. C. Jr., Wittum, T., Morrison, M. (2007). Development and Application of Real-Time PCR Assays for Quantification of erm Genes Conferring Resistance to Macrolides-Lincosamides-Streptogramin B in Livestock Manure and Manure Management Systems. Appl. Environ. Microbiol. 73: 4407-4416 [Abstract] [Full Text]  
  • Puopolo, K. M., Klinzing, D. C., Lin, M. P., Yesucevitz, D. L., Cieslewicz, M. J. (2007). A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus. J Med Microbiol 56: 947-955 [Abstract] [Full Text]  
  • Luthje, P., von Kockritz-Blickwede, M., Schwarz, S. (2007). Identification and characterization of nine novel types of small staphylococcal plasmids carrying the lincosamide nucleotidyltransferase gene lnu(A). J Antimicrob Chemother 59: 600-606 [Abstract] [Full Text]  
  • Hawkyard, C. V., Koerner, R. J. (2007). The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J Antimicrob Chemother 59: 347-358 [Abstract] [Full Text]  
  • Szczepanowski, R., Krahn, I., Bohn, N., Puhler, A., Schluter, A. (2007). Novel Macrolide Resistance Module Carried by the IncP-1{beta} Resistance Plasmid pRSB111, Isolated from a Wastewater Treatment Plant. Antimicrob. Agents Chemother. 51: 673-678 [Abstract] [Full Text]  
  • Jindal, A., Kocherginskaya, S., Mehboob, A., Robert, M., Mackie, R. I., Raskin, L., Zilles, J. L. (2006). Antimicrobial Use and Resistance in Swine Waste Treatment Systems. Appl. Environ. Microbiol. 72: 7813-7820 [Abstract] [Full Text]  
  • Nash, K. A., Andini, N., Zhang, Y., Brown-Elliott, B. A., Wallace, R. J. Jr. (2006). Intrinsic macrolide resistance in rapidly growing mycobacteria.. Antimicrob. Agents Chemother. 50: 3476-3478 [Abstract] [Full Text]  
  • Ardanuy, C., Fenoll, A., Berron, S., Calatayud, L., Linares, J., the Spanish Pneumococcal Infection Study Network, (2006). Increase of the M Phenotype among Erythromycin-Resistant Streptococcus pneumoniae Isolates from Spain Related to the Serotype 14 Variant of the Spain9V-3 Clone.. Antimicrob. Agents Chemother. 50: 3162-3165 [Abstract] [Full Text]  
  • Gibreel, A., Taylor, D. E. (2006). Macrolide resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 58: 243-255 [Abstract] [Full Text]  
  • Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., Vester, B. (2006). The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A Antibiotics.. Antimicrob. Agents Chemother. 50: 2500-2505 [Abstract] [Full Text]  
  • He, J., Miyazaki, H., Anaya, C., Yu, F., Yeudall, W. A., Lewis, J. P. (2006). Role of Porphyromonas gingivalis FeoB2 in Metal Uptake and Oxidative Stress Protection. Infect. Immun. 74: 4214-4223 [Abstract] [Full Text]  
  • Cassone, M., D'Andrea, M. M., Iannelli, F., Oggioni, M. R., Rossolini, G. M., Pozzi, G. (2006). DNA microarray for detection of macrolide resistance genes.. Antimicrob. Agents Chemother. 50: 2038-2041 [Abstract] [Full Text]  
  • Ojo, K. K., Ruehlen, N. L., Close, N. S., Luis, H., Bernardo, M., Leitao, J., Roberts, M. C. (2006). The presence of a conjugative Gram-positive Tn2009 in Gram-negative commensal bacteria. J Antimicrob Chemother 57: 1065-1069 [Abstract] [Full Text]  
  • Gygax, S. E., Schuyler, J. A., Kimmel, L. E., Trama, J. P., Mordechai, E., Adelson, M. E. (2006). Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.. Antimicrob. Agents Chemother. 50: 1875-1877 [Abstract] [Full Text]  
  • Littauer, P., Caugant, D. A., Sangvik, M., Hoiby, E. A., Sundsfjord, A., Simonsen, G. S., the Norwegian Macrolide Study Group, (2006). Macrolide-Resistant Streptococcus pyogenes in Norway: Population Structure and Resistance Determinants.. Antimicrob. Agents Chemother. 50: 1896-1899 [Abstract] [Full Text]  
  • Luthje, P., Schwarz, S. (2006). Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide-lincosamide resistance phenotypes and genotypes. J Antimicrob Chemother 57: 966-969 [Abstract] [Full Text]  
  • Ojo, K. K., Striplin, M. J., Ulep, C. C., Close, N. S., Zittle, J., Luis, H., Bernardo, M., Leitao, J., Roberts, M. C. (2006). Staphylococcus Efflux msr(A) Gene Characterized in Streptococcus, Enterococcus, Corynebacterium, and Pseudomonas Isolates. Antimicrob. Agents Chemother. 50: 1089-1091 [Abstract] [Full Text]  
  • Amezaga, M. R., McKenzie, H. (2006). Molecular epidemiology of macrolide resistance in {beta}-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother 57: 443-449 [Abstract] [Full Text]  
  • Grivea, I. N., Al-Lahham, A., Katopodis, G. D., Syrogiannopoulos, G. A., Reinert, R. R. (2006). Resistance to Erythromycin and Telithromycin in Streptococcus pyogenes Isolates Obtained between 1999 and 2002 from Greek Children with Tonsillopharyngitis: Phenotypic and Genotypic Analysis. Antimicrob. Agents Chemother. 50: 256-261 [Abstract] [Full Text]  
  • Cochetti, I., Vecchi, M., Mingoia, M., Tili, E., Catania, M. R., Manzin, A., Varaldo, P. E., Montanari, M. P. (2005). Molecular Characterization of Pneumococci with Efflux-Mediated Erythromycin Resistance and Identification of a Novel mef Gene Subclass, mef(I). Antimicrob. Agents Chemother. 49: 4999-5006 [Abstract] [Full Text]  
  • Spigaglia, P., Barbanti, F., Mastrantonio, P. (2005). Horizontal Transfer of Erythromycin Resistance from Clostridium difficile to Butyrivibrio fibrisolvens. Antimicrob. Agents Chemother. 49: 5142-5145 [Abstract] [Full Text]  
  • Woo, P. C. Y., Tse, H., Wong, S. S. Y., Tse, C. W. S., Fung, A. M. Y., Tam, D. M. W., Lau, S. K. P., Yuen, K.-y. (2005). Life-Threatening Invasive Helcococcus kunzii Infections in Intravenous-Drug Users and ermA-Mediated Erythromycin Resistance. J. Clin. Microbiol. 43: 6205-6208 [Abstract] [Full Text]  
  • Madsen, C. T., Jakobsen, L., Buriankova, K., Doucet-Populaire, F., Pernodet, J.-L., Douthwaite, S. (2005). Methyltransferase Erm(37) Slips on rRNA to Confer Atypical Resistance in Mycobacterium tuberculosis. J. Biol. Chem. 280: 38942-38947 [Abstract] [Full Text]  
  • Wierzbowski, A. K., Boyd, D., Mulvey, M., Hoban, D. J., Zhanel, G. G. (2005). Expression of the mef(E) Gene Encoding the Macrolide Efflux Pump Protein Increases in Streptococcus pneumoniae with Increasing Resistance to Macrolides. Antimicrob. Agents Chemother. 49: 4635-4640 [Abstract] [Full Text]  
  • Davignon, L., Walter, E. A., Mueller, K. M., Barrozo, C. P., Stenger, D. A., Lin, B., on behalf of the Epidemic Outbreak Surveillance Co, (2005). Use of Resequencing Oligonucleotide Microarrays for Identification of Streptococcus pyogenes and Associated Antibiotic Resistance Determinants. J. Clin. Microbiol. 43: 5690-5695 [Abstract] [Full Text]  
  • Culebras, E., Rodriguez-Avial, I., Betriu, C., Picazo, J. J. (2005). Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae. J Antimicrob Chemother 56: 836-840 [Abstract] [Full Text]  
  • Sangvik, M., Littauer, P., Simonsen, G. S., Sundsfjord, A., Dahl, K. H. (2005). mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway. J Antimicrob Chemother 56: 841-846 [Abstract] [Full Text]  
  • Rantala, M., Huikko, S., Huovinen, P., Jalava, J., the Finnish Study Group for Antimicrobial Resistan, (2005). Prevalence and Molecular Genetics of Macrolide Resistance among Streptococcus pneumoniae Isolates Collected in Finland in 2002. Antimicrob. Agents Chemother. 49: 4180-4184 [Abstract] [Full Text]  
  • Ambrose, K. D., Nisbet, R., Stephens, D. S. (2005). Macrolide Efflux in Streptococcus pneumoniae Is Mediated by a Dual Efflux Pump (mel and mef) and Is Erythromycin Inducible. Antimicrob. Agents Chemother. 49: 4203-4209 [Abstract] [Full Text]  
  • Madsen, C. T., Jakobsen, L., Douthwaite, S. (2005). Mycobacterium smegmatis Erm(38) Is a Reluctant Dimethyltransferase. Antimicrob. Agents Chemother. 49: 3803-3809 [Abstract] [Full Text]  
  • Davis, K. A., Crawford, S. A., Fiebelkorn, K. R., Jorgensen, J. H. (2005). Induction of Telithromycin Resistance by Erythromycin in Isolates of Macrolide-Resistant Staphylococcus spp.. Antimicrob. Agents Chemother. 49: 3059-3061 [Abstract] [Full Text]  
  • Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56: 20-51 [Abstract] [Full Text]  
  • De Leener, E., Martel, A., De Graef, E. M., Top, J., Butaye, P., Haesebrouck, F., Willems, R., Decostere, A. (2005). Molecular Analysis of Human, Porcine, and Poultry Enterococcus faecium Isolates and Their erm(B) Genes. Appl. Environ. Microbiol. 71: 2766-2770 [Abstract] [Full Text]  
  • Littauer, P., Sangvik, M., Caugant, D. A., Hoiby, E. A., Simonsen, G. S., Sundsfjord, A., the Norwegian Macrolide Study Group, (2005). Molecular Epidemiology of Macrolide-Resistant Isolates of Streptococcus pneumoniae Collected from Blood and Respiratory Specimens in Norway. J. Clin. Microbiol. 43: 2125-2132 [Abstract] [Full Text]  
  • Klaassen, C. H. W., Mouton, J. W. (2005). Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E). Antimicrob. Agents Chemother. 49: 1271-1278 [Full Text]  
  • Steward, C. D., Raney, P. M., Morrell, A. K., Williams, P. P., McDougal, L. K., Jevitt, L., McGowan, J. E. Jr., Tenover, F. C. (2005). Testing for Induction of Clindamycin Resistance in Erythromycin-Resistant Isolates of Staphylococcus aureus. J. Clin. Microbiol. 43: 1716-1721 [Abstract] [Full Text]  
  • Ardanuy, C., Tubau, F., Linares, J., Dominguez, M. A., Pallares, R., Martin, R., The Spanish Pneumococcal Infection Study Network, (2005). Distribution of Subclasses mefA and mefE of the mefA Gene among Clinical Isolates of Macrolide-Resistant (M-Phenotype) Streptococcus pneumoniae, Viridans Group Streptococci, and Streptococcus pyogenes. Antimicrob. Agents Chemother. 49: 827-829 [Abstract] [Full Text]  
  • Barbosa, T. M., Serra, C. R., La Ragione, R. M., Woodward, M. J., Henriques, A. O. (2005). Screening for Bacillus Isolates in the Broiler Gastrointestinal Tract. Appl. Environ. Microbiol. 71: 968-978 [Abstract] [Full Text]  
  • Nash, K. A., Zhang, Y., Brown-Elliott, B. A., Wallace, R. J. Jr (2005). Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 55: 170-177 [Abstract] [Full Text]  
  • Xiong, L., Korkhin, Y., Mankin, A. S. (2005). Binding Site of the Bridged Macrolides in the Escherichia coli Ribosome. Antimicrob. Agents Chemother. 49: 281-288 [Abstract] [Full Text]  
  • Kehrenberg, C., Schwarz, S. (2005). dfrA20, a Novel Trimethoprim Resistance Gene from Pasteurella multocida. Antimicrob. Agents Chemother. 49: 414-417 [Abstract] [Full Text]  
  • Desjardins, M., Delgaty, K. L., Ramotar, K., Seetaram, C., Toye, B. (2004). Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results. J. Clin. Microbiol. 42: 5620-5623 [Abstract] [Full Text]  
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. (2004). Antibiotic Susceptibility in Neonatal Invasive Isolates of Streptococcus agalactiae in a 2-Year Nationwide Surveillance Study in Germany. Antimicrob. Agents Chemother. 48: 4444-4446 [Abstract] [Full Text]  
  • Brown, S. D., Farrell, D. J., Morrissey, I. (2004). Prevalence and Molecular Analysis of Macrolide and Fluoroquinolone Resistance among Isolates of Streptococcus pneumoniae Collected during the 2000-2001 PROTEKT US Study. J. Clin. Microbiol. 42: 4980-4987 [Abstract] [Full Text]  
  • Szczepanowski, R., Krahn, I., Linke, B., Goesmann, A., Puhler, A., Schluter, A. (2004). Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system. Microbiology 150: 3613-3630 [Abstract] [Full Text]  
  • Hayes, J. R., English, L. L., Carr, L. E., Wagner, D. D., Joseph, S. W. (2004). Multiple-Antibiotic Resistance of Enterococcus spp. Isolated from Commercial Poultry Production Environments. Appl. Environ. Microbiol. 70: 6005-6011 [Abstract] [Full Text]  
  • Ojo, K. K., Ulep, C., Van Kirk, N., Luis, H., Bernardo, M., Leitao, J., Roberts, M. C. (2004). The mef(A) Gene Predominates among Seven Macrolide Resistance Genes Identified in Gram-Negative Strains Representing 13 Genera, Isolated from Healthy Portuguese Children. Antimicrob. Agents Chemother. 48: 3451-3456 [Abstract] [Full Text]  
  • Riska, P. F., Kutlin, A., Ajiboye, P., Cua, A., Roblin, P. M., Hammerschlag, M. R. (2004). Genetic and Culture-Based Approaches for Detecting Macrolide Resistance in Chlamydia pneumoniae. Antimicrob. Agents Chemother. 48: 3586-3590 [Abstract] [Full Text]  
  • Chollet, R., Chevalier, J., Bryskier, A., Pages, J.-M. (2004). The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother. 48: 3621-3624 [Abstract] [Full Text]  
  • Kresken, M., Henrichfreise, B., Bagel, S., Brauers, J., Wiedemann, B. (2004). High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin. Antimicrob. Agents Chemother. 48: 3193-3195 [Abstract] [Full Text]  
  • Daly, M. M., Doktor, S., Flamm, R., Shortridge, D. (2004). Characterization and Prevalence of MefA, MefE, and the Associated msr(D) Gene in Streptococcus pneumoniae Clinical Isolates. J. Clin. Microbiol. 42: 3570-3574 [Abstract] [Full Text]  
  • Jackson, C. R., Fedorka-Cray, P. J., Barrett, J. B., Ladely, S. R. (2004). Effects of Tylosin Use on Erythromycin Resistance in Enterococci Isolated from Swine. Appl. Environ. Microbiol. 70: 4205-4210 [Abstract] [Full Text]  
  • Del Grosso, M., Scotto d'Abusco, A., Iannelli, F., Pozzi, G., Pantosti, A. (2004). Tn2009, a Tn916-Like Element Containing mef(E) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48: 2037-2042 [Abstract] [Full Text]  
  • Spiliopoulou, I., Petinaki, E., Papandreou, P., Dimitracopoulos, G. (2004). erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece. J Antimicrob Chemother 53: 814-817 [Abstract] [Full Text]  
  • Reinert, R. R., Lutticken, R., Sutcliffe, J. A., Tait-Kamradt, A., Cil, M. Y., Schorn, H. M., Bryskier, A., Al-Lahham, A. (2004). Clonal Relatedness of Erythromycin-Resistant Streptococcus pyogenes Isolates in Germany. Antimicrob. Agents Chemother. 48: 1369-1373 [Abstract] [Full Text]  
  • Hasenbein, M. E., Warner, J. E., Lambert, K. G., Cole, S. E., Onderdonk, A. B., McAdam, A. J. (2004). Detection of Multiple Macrolide- and Lincosamide-Resistant Strains of Streptococcus pyogenes from Patients in the Boston Area. J. Clin. Microbiol. 42: 1559-1563 [Abstract] [Full Text]  
  • Jost, B. H., Trinh, H. T., Songer, J. G., Billington, S. J. (2004). A Second Tylosin Resistance Determinant, Erm B, in Arcanobacterium pyogenes. Antimicrob. Agents Chemother. 48: 721-727 [Abstract] [Full Text]  
  • Farrell, D. J., Morrissey, I., Bakker, S., Morris, L., Buckridge, S., Felmingham, D. (2004). Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm(B)- and mef(A)-Mediated Macrolide Resistance. J. Clin. Microbiol. 42: 764-768 [Abstract] [Full Text]  
  • Buriankova, K., Doucet-Populaire, F., Dorson, O., Gondran, A., Ghnassia, J.-C., Weiser, J., Pernodet, J.-L. (2004). Molecular Basis of Intrinsic Macrolide Resistance in the Mycobacterium tuberculosis Complex. Antimicrob. Agents Chemother. 48: 143-150 [Abstract] [Full Text]  
  • Bozdogan, B., Galopin, S., Leclercq, R. (2004). Characterization of a New erm-Related Macrolide Resistance Gene Present in Probiotic Strains of Bacillus clausii. Appl. Environ. Microbiol. 70: 280-284 [Abstract] [Full Text]  
  • Cousin, S. Jr., Whittington, W. L. H., Roberts, M. C. (2003). Acquired Macrolide Resistance Genes in Pathogenic Neisseria spp. Isolated between 1940 and 1987. Antimicrob. Agents Chemother. 47: 3877-3880 [Abstract] [Full Text]  
  • Hall, R., Partridge, S., Bradford, P. A., Bush, K., Jacoby, G. A., Rice, L. B., Young, L. S. (2003). Unambiguous Numbering of Antibiotic Resistance Genes. Antimicrob. Agents Chemother. 47: 3998-3999 [Full Text]  
  • Stroman, P., Muller, C. C., Sorensen, K. I. (2003). Heat Shock Treatment Increases the Frequency of Loss of an Erythromycin Resistance-Encoding Transposable Element from the Chromosome of Lactobacillus crispatus CHCC3692. Appl. Environ. Microbiol. 69: 7173-7180 [Abstract] [Full Text]  
  • Jost, B. H., Field, A. C., Trinh, H. T., Songer, J. G., Billington, S. J. (2003). Tylosin Resistance in Arcanobacterium pyogenes Is Encoded by an Erm X Determinant. Antimicrob. Agents Chemother. 47: 3519-3524 [Abstract] [Full Text]  
  • Woo, P. C. Y., To, A. P. C., Tse, H., Lau, S. K. P., Yuen, K.-y. (2003). Clinical and Molecular Epidemiology of Erythromycin-Resistant Beta-Hemolytic Lancefield Group G Streptococci Causing Bacteremia. J. Clin. Microbiol. 41: 5188-5191 [Abstract] [Full Text]  
  • Jacobs, M. R., Bajaksouzian, S., Appelbaum, P. C. (2003). Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci. J Antimicrob Chemother 52: 809-812 [Abstract] [Full Text]  
  • Nash, K. A. (2003). Intrinsic Macrolide Resistance in Mycobacterium smegmatis Is Conferred by a Novel erm Gene, erm(38). Antimicrob. Agents Chemother. 47: 3053-3060 [Abstract] [Full Text]  
  • Lopardo, H. A., Vidal, P., Jeric, P., Centron, D., Paganini, H., Facklam, R. R., Elliott, J. (2003). Six-Month Multicenter Study on Invasive Infections Due to Group B Streptococci in Argentina. J. Clin. Microbiol. 41: 4688-4694 [Abstract] [Full Text]  
  • Fiebelkorn, K. R., Crawford, S. A., McElmeel, M. L., Jorgensen, J. H. (2003). Practical Disk Diffusion Method for Detection of Inducible Clindamycin Resistance in Staphylococcus aureus and Coagulase-Negative Staphylococci. J. Clin. Microbiol. 41: 4740-4744 [Abstract] [Full Text]  
  • Tang, P., Low, D. E., Atkinson, S., Pike, K., Ashi-Sulaiman, A., Simor, A., Richardson, S., Willey, B. M. (2003). Investigation of Staphylococcus aureus Isolates Identified as Erythromycin Intermediate by the Vitek-1 System: Comparison with Results Obtained with the Vitek-2 and Phoenix Systems. J. Clin. Microbiol. 41: 4823-4825 [Abstract] [Full Text]  
  • Giovanetti, E., Brenciani, A., Lupidi, R., Roberts, M. C., Varaldo, P. E. (2003). Presence of the tet(O) Gene in Erythromycin- and Tetracycline-Resistant Strains of Streptococcus pyogenes and Linkage with either the mef(A) or the erm(A) Gene. Antimicrob. Agents Chemother. 47: 2844-2849 [Abstract] [Full Text]  
  • Portillo, A., Gastanares, M. J., Ruiz-Larrea, F., Torres, C. (2003). Clonal diversity among erythromycin-resistant {beta}-haemolytic Streptococcus isolates in La Rioja, Spain. J Antimicrob Chemother 52: 485-488 [Abstract] [Full Text]  
  • Kehoe, L. E., Snidwongse, J., Courvalin, P., Rafferty, J. B., Murray, I. A. (2003). Structural Basis of Synercid(R) (Quinupristin-Dalfopristin) Resistance in Gram-positive Bacterial Pathogens. J. Biol. Chem. 278: 29963-29970 [Abstract] [Full Text]  
  • Syrogiannopoulos, G. A., Grivea, I. N., Ednie, L. M., Bozdogan, B., Katopodis, G. D., Beratis, N. G., Davies, T. A., Appelbaum, P. C. (2003). Antimicrobial Susceptibility and Macrolide Resistance Inducibility of Streptococcus pneumoniae Carrying erm(A), erm(B), or mef(A). Antimicrob. Agents Chemother. 47: 2699-2702 [Abstract] [Full Text]  
  • Montanari, M. P., Cochetti, I., Mingoia, M., Varaldo, P. E. (2003). Phenotypic and Molecular Characterization of Tetracycline- and Erythromycin-Resistant Strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47: 2236-2241 [Abstract] [Full Text]  
  • Katz, K. C., McGeer, A. J., Duncan, C. L., Ashi-Sulaiman, A., Willey, B. M., Sarabia, A., McCann, J., Pong-Porter, S., Rzayev, Y., de Azavedo, J. S., Low, D. E. (2003). Emergence of Macrolide Resistance in Throat Culture Isolates of Group A Streptococci in Ontario, Canada, in 2001. Antimicrob. Agents Chemother. 47: 2370-2372 [Abstract] [Full Text]  
  • Morosini, M.-I., Canton, R., Loza, E., del Campo, R., Almaraz, F., Baquero, F. (2003). Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin. J Antimicrob Chemother 52: 50-55 [Abstract] [Full Text]  
  • Farrell, D. J., Douthwaite, S., Morrissey, I., Bakker, S., Poehlsgaard, J., Jakobsen, L., Felmingham, D. (2003). Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study. Antimicrob. Agents Chemother. 47: 1777-1783 [Abstract] [Full Text]  
  • Karlsson, M., Fellstrom, C., Gunnarsson, A., Landen, A., Franklin, A. (2003). Antimicrobial Susceptibility Testing of Porcine Brachyspira (Serpulina) Species Isolates. J. Clin. Microbiol. 41: 2596-2604 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, M. C.
Right arrow Articles by Seppala, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, M. C.
Right arrow Articles by Seppala, H.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»